1. Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?. Issue 5 (May 2018) Authors: Weekes, Colin D; Clark, Jeffrey W; Zhu, Andrew X Journal: Lancet oncology Issue: Volume 19:Issue 5(2018) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy. (4th June 2020) Authors: Michelakos, Theodoros; Cai, Lei; Villani, Vincenzo; Sabbatino, Francesco; Kontos, Filippos; Fernández-del Castillo, Carlos; Yamada, Teppei; Neyaz, Azfar; Taylor, Martin S; Deshpande, Vikram; Kurokawa, Tomohiro; Ting, David T; Qadan, Motaz; Weekes, Colin D; Allen, Jill N; Clark, Jeffrey W; Hong, T... Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 2(2021) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗